Worldwide offers an oncology-dedicated team to support biotechnology companies in developing next-generation cancer therapies. We specialize in early phase oncology research, with over 70% of our active portfolio consisting of Phase I/II and first-in-human clinical trials. We provide full-service support across Phase I through III development, with particular expertise in managing complex aspects, including Project Optimus trial designs, global cohort management, and flexible amendment processes. Our flexible approach and deep understanding of both solid tumor and hematologic indications position us to handle complex study designs, novel endpoints, and cutting-edge technologies while remaining nimble enough to adapt quickly to protocol amendments or breakthrough designations.
Read our fact sheet to learn more about offerings from our team that brings significant experience to the table, averaging 9+ years of oncology expertise across key roles, including project management, clinical trial leadership, data management, and clinical science.
